Impact Omics
Timeline
12 events since 2022Board
Capital
Filings
Financial
Establishments
20222023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 18 days before the deadline
2025
Liquidity more than quadruples current ratio 1.12 The current ratio rises from 0.28 to 1.12. Short-term debt falls from €202,264 to €61,748.
Appointment: VGD Bedrijfsrevisoren BV (company auditor)259 new shares · 230 new shares · 212 new shares · General meeting of 19-09-20257 points ▸
- General meeting, 19-09-2025
- Auditor appointment, VGD Bedrijfsrevisoren BV (company auditor)
- Auditor report, 18-09-2025
- Board meeting, 18-09-2025
- Share issue, €259
- 2,618 shares
- Amendment of the articles, article 5
- The deed holds 6 more points.
Annual accounts 2024 filed PDFmicro format · 48 days late
2024
Weakest financial year net -€318,668 The net result drops to -€318,668, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFmicro format · 29 days before the deadline
2023
Liquidity more than 6 times current ratio 1.11 The current ratio rises from 0.17 to 1.11. Short-term debt falls from €224,828 to €219,340.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0779683030
Capital contribution of €220,000Issue of 440 shares · Issue of 347 shares · 477 shares · General meeting of 28-09-20233 points ▸
- General meeting, 28-09-2023
- Capital contribution, €220,000
- 1,917 shares
- The deed holds 9 more points.
Annual accounts 2022 filed PDFmicro format · 11 days before the deadline
2022
IncorporationFounding capital of €7,500, 1,000 shares · Founder: VERGAUWE Nicolas Hannes Roger (comparant oprichter) · Appointment: CURIOSITER (director) · published on 06-01-20224 points ▸
- Founder, VERGAUWE Nicolas Hannes Roger (comparant oprichter)
- Founding capital, €7,500, 1,000 shares
- Director appointment, CURIOSITER
- Permanent representative, VERGAUWE Nicolas Hannes Roger
- The deed holds 3 more points.
First establishment Ambachtenlaan 1, Leuven
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Impact Omics was incorporated on 4 January 2022 as a private limited company by one natural person, with a starting capital of €7,500.12 In 2025 the capital was increased.3 CURIOSITER is director of the company, appointed by deed of 06-01-2022.2 Total assets rose from €50,449 in 2022 to €102,349 in 2025 and headcount from 0.8 full-time equivalents in 2023 to 1 in 2025.4